Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based immunization

Vaccine

Volumn 17, Issue 23-24, 1999, Pages 3160-3170

  Hu, Guo Jun ^a   Wang, Richard Y H ^a   Han, Dai Shu ^a   Alter, Harvey J ^a   Shih, J Wai Kuo ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antibodies; CTL; DNA vaccine; HCV

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHRONIC DISEASE; CYTOTOXIC T LYMPHOCYTE; DNA SEQUENCE; EFFECTOR CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; VIRUS CHARACTERIZATION; VIRUS CORE; VIRUS GENOME;

EID: 0033529517     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00130-9     Document Type: Article

References (39)

1. Choo Q-L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
2. Alter H.J., Purcell R.H., Shih J.W.K., Melpolder J.C., Houghton M., Choo Q-L., Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New Engl J Med. 321:1989;1494-1500.
3. Kuo G., Choo Q.-L., Alter H.J., Gitnick G.L., Redeker A.G., Purcell R.H., Miyamura T., Dienstag M.J., Alter J.L., Stevens C.E., Tegtmeier G.E., Bonino F., Colombo M., Lee W.-S., Kuo G., Berger K., Shuter J.R., Overby L.R., Bradley D.W., Houghton M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 244:1989;362-364.
4. van der Poel C.L., Reesink H.W., Lelie P.N., Leentvaar-Kuypers A., Choo Q-L., Kuo G. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet. 2:1989;297-298.
5. Esteban J.I., Esteban R., Viladomiu L., Lopez-Talavera J.C., Gonzalez A., Hernandez J.M., Roget M., Vargas V., Genesca J., Buti M., Guardia J., Houghton M., Choo Q-L., Kuo G. Hepatitis C virus antibodies among risk groups in Spain. Lancet. 2:1989;294-297.
6. Miyanura T., Saito I., Katayama T., Kikuchi S., Tateda A., Houghton M., Choo Q.-L., Kuo G. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA. 87:1990;983-987.
7. Choo Q.-L., Richman K.H., Han J.H., Berger K., Lee C., Gllegos C., Coit D., Medina A., Barr P.J., Weiner A.J., Bradley D.W., Kuo G., Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 88:1991;2451-2455.
8. Kato N., Hijikata M., Ootsuyama Y., Nakagawa M., Ohkoshi S., Sugimura T., Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA. 87:1990;9524-9528.
9. Takamizawa A., Mori C., Fuke I., Manabe S., Murakami S., Fujita J., Onishi E., Andoh T., Yoshida I., Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carries. J Virol. 65:1991;1105-1113.
10. Houghton M., Selby M., Eeiner A., Choo Q-L. Hepatitis C virus: structure, protein products and processing of the polyprotein precursor. Curr. Stud. Hematol. Blood Transf. 61:1994;1-11 Karger, Basel.
11. Maeno M., Kaminaka H., Sugimoto H., Esumi M., Hayashi N., Komatsu K., Abs K., Sekiguchi S., Yano M., Mizuno K., Shikata T. A cDNA clone closely associated with non-A, non-B hepatitis. Nucleic Acids Res. 18:1990;2685-2689.
12. Bradley D.W., McCaustland K.A., Cook E.H., Schable C.A., Ebert J.W., Maynard J.E. Posttransfusion non-A, non-B hepatitis in chimpanzees: physicochemical evidence that the tubule-forming agent is a small, enveloped virus. Gastroenterology. 88:1985;773-779.
13. Houghton M., Weiner A., Han J., Kuo G., Choo Q-L. Molecular biology of the hepatitis C virus: implications for diagnosis, development and control of viral disease. Hepatology. 14:1991;381-388.
14. Choo Q-L., Kuo G., Ralston R., Weiner A., Chien D., Van Nest G., Han J., Berger K., Thudium K., Kuo C., Kansonpon J., McFarland J., Tabrizi, A., Ching K., Moss B., Cummins L.B., Houghton M., Muchmore E. Vaccination of Chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci USA. 91:1994;1294-1298.
15. Tokushige K., Wakita T., Pachuk C., Moradpour D., Weiner D.B., Zurawski V.R. Jr, Wands J.R. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology. 24:1996;14-20.
16. Chen Z., Wang R.Y-H., Alter H.J., Shih J.W-K. Genetic immunization of mice with plasmids containing hepatitis C virus core protein-encoding DNA. Vaccine Res. 4:1995;135-143.
17. Major M., Vitvitski L., Mink M.A., Schleef M., Whalen R.G., Trepo C., Inchauspe G. DNA-based immunization with chimeric vectors for the induction of immune responses against the hepatitis C virus nucleocapsid. J Virol. 69:1995;5798-5805.
18. Lagging L.M., Meyer K., Hoft D., Houghton M., Belshe R., Ray R. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol. 69:1995;5859-5863.
19. Shirai M., Chen M., Arichi T., Masaki T., Nishioka M., Newman M., Nakazawa T., Feinstone S.M., Berzofsky J.A. Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines. J Infection Diseases. 173:1996;24-31.
20. Bruna-Romero O., Lasarte J.J., Wilkinson G., Grace K., Clarke B., Borras-Cuesta F., Prieto J. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus. Hepatology. 25:1997;470-477.
21. Saito T., Sherman G.J., Kurokohchi K., Guo Z.-P., Donets M., Yu W.M.-Y., Berzofsky J.A., Akatsuka T., Feinstone S.M. Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice. Gastroenterology. 112:1997;1321-1330.
22. Nakano I., Maertens G., Major M.E., Vitvitski L., Dubuisson J., Fournillier A., De Martynoff G., Trepo C., Inchauspe G. Immunization with plasmid DNA encoding hepatitis C virus envelope E2 antigenic domains induces antibodies whose immune reactivity is linked to the injection mode. J Virol. 71:1997;7101-7109.
23. Chen Z., Berkower L., Wang R.Y-H., Ching W-M., Alter H.J., Shih J.W-K. Genetic control of the murine humoral response to distinct epitopes of Hepatitis C virus core protein. J Vira Hepat. 2:1995;9-17.
24. Shirai M., Okada H., Nishioka M., Akatsuka T., Wychowski C., Houghten R., Pendleton C.D., Feinstone S.M., Berzofsky J.A. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol. 68:1994;3334-3342.
25. Koziel M.J., Dudley D., Afdhal N., Choo Q.-L., Houghton M., Ralston R., Walker B. Hepatitis C Virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 67:1993;7522-7532.
26. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., Feigner P.L. Direct gene transfer into mouse muscle in vivo. Science. 247:1990;1465-1468.
27. Ulmer J.B., Donnelly J.J., Parker S., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Randall Deck R., DeWitt C.M., Friedman A., Hawe L.A., Leander K.P., Martinez D., Perry H.C., Shiver J.W., Montgomery D.L., Liu M.A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
28. Wang B., Uren K.E., Srikantan V., Agadjianyan M.G., Dang K., Refaeli Y., Sato A.I., Boyer J., Williams W.V., Weiner D.B. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 90:1993;4156-4160.
29. Michel M.L., Davis H.L., Schleef M., Mancini M., Tiollais P., Whalen R.G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B virus infection in human. Proc Natl Acad Sci USA. 92:1995;5307-5311.
30. Schirmbeck R., Bohm W., Ando K., Chisari F.V., Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol. 69:1997;5929-5934.
31. Ramsay A.J., Ramshaw I.A., Ada G.L. immunization (Overview). Immunol Cell Biol. 75:1997;360-363.
32. Townsend A.R.M., Bodmer H.C. Antigen recognition by class I-restricted T lymphocyte. Annu Rev Immunol. 7:1989;601-624.
33. Yewdell J.W., Bennink J.R. Cell biology of antigen processing and presentation to major histocompetibility complex class I molecule-restricted T lymphocyte. Adv Immunol. 52:1992;1-123.
34. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol. 11:1993;403-450.
35. Rammensee H.G., Falk K., Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol. 11:1993;213-244.
36. McMichael A., Klenerman P., Rowland-Jones S., Gotch F., Moss P. Recognition of viral antigens at the cell surface. Cancer Surveys. 22:1995;51-62.
37. Monaco J.J. A molecular model of MHC class I restricted antigen processing. Immunol Today. 13:1992;173-179.
38. Rammensee H.G., Friede T., Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics. 41:1995;178-228.
39. Farci P., Alter H.J., Wong D.C., Miller R.H., Govindarajan S., Engle R., Shapiro M., Purcell R.H. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA. 91:1994;7792-7796.